238 related articles for article (PubMed ID: 17432710)
1. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma.
Semrad TJ; O'Donnell R; Wun T; Chew H; Harvey D; Zhou H; White RH
J Neurosurg; 2007 Apr; 106(4):601-8. PubMed ID: 17432710
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
[TBL] [Abstract][Full Text] [Related]
3. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with recurrent venous thromboembolism in patients with malignant disease.
Lin J; Proctor MC; Varma M; Greenfield LJ; Upchurch GR; Henke PK
J Vasc Surg; 2003 May; 37(5):976-83. PubMed ID: 12756342
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism in ovarian cancer.
Rodriguez AO; Wun T; Chew H; Zhou H; Harvey D; White RH
Gynecol Oncol; 2007 Jun; 105(3):784-90. PubMed ID: 17408726
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism after spinal cord injury: incidence, time course, and associated risk factors in 16,240 adults and children.
Jones T; Ugalde V; Franks P; Zhou H; White RH
Arch Phys Med Rehabil; 2005 Dec; 86(12):2240-7. PubMed ID: 16344018
[TBL] [Abstract][Full Text] [Related]
7. The occurrence of venous thromboembolism in cancer patients following major surgery.
Toledano TH; Kondal D; Kahn SR; Tagalakis V
Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
[TBL] [Abstract][Full Text] [Related]
8. A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors.
Streiff MB; Ye X; Kickler TS; Desideri S; Jani J; Fisher J; Grossman SA
J Neurooncol; 2015 Sep; 124(2):299-305. PubMed ID: 26100546
[TBL] [Abstract][Full Text] [Related]
9. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas.
Streiff MB; Segal J; Grossman SA; Kickler TS; Weir EG
Cancer; 2004 Apr; 100(8):1717-23. PubMed ID: 15073862
[TBL] [Abstract][Full Text] [Related]
10. Incidence of venous thromboembolism in patients undergoing craniotomy and motor mapping for glioma without intraoperative mechanical prophylaxis to the contralateral leg.
Auguste KI; Quinones-Hinojosa A; Gadkary C; Zada G; Lamborn KR; Berger MS
J Neurosurg; 2003 Oct; 99(4):680-4. PubMed ID: 14567603
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
[TBL] [Abstract][Full Text] [Related]
12. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism and survival in patients with high-grade glioma.
Simanek R; Vormittag R; Hassler M; Roessler K; Schwarz M; Zielinski C; Pabinger I; Marosi C
Neuro Oncol; 2007 Apr; 9(2):89-95. PubMed ID: 17327573
[TBL] [Abstract][Full Text] [Related]
14. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures.
White RH; Zhou H; Romano PS
Thromb Haemost; 2003 Sep; 90(3):446-55. PubMed ID: 12958614
[TBL] [Abstract][Full Text] [Related]
15. High incidence of venous thromboembolic events in lung transplant recipients.
Kahan ES; Petersen G; Gaughan JP; Criner GJ
J Heart Lung Transplant; 2007 Apr; 26(4):339-44. PubMed ID: 17403474
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.
Eriksson H; Lundström T; Wåhlander K; Clason SB; Schulman S;
Thromb Haemost; 2005 Sep; 94(3):522-7. PubMed ID: 16268466
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive assessment of prophylactic preoperative inferior vena cava filters for major spinal reconstruction in adults.
McClendon J; Oʼshaughnessy BA; Smith TR; Sugrue PA; Halpin RJ; Morasch M; Koski T; Ondra SL
Spine (Phila Pa 1976); 2012 Jun; 37(13):1122-9. PubMed ID: 22281478
[TBL] [Abstract][Full Text] [Related]
18. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.
Baglin T; Luddington R; Brown K; Baglin C
Lancet; 2003 Aug; 362(9383):523-6. PubMed ID: 12932383
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma and venous thromboembolism: influence on mortality.
Mahajan A; Wun T; Chew H; White RH
Thromb Res; 2014 May; 133 Suppl 2():S23-8. PubMed ID: 24862141
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in uterine cancer.
Rodriguez AO; Gonik AM; Zhou H; Leiserowitz GS; White RH
Int J Gynecol Cancer; 2011 Jul; 21(5):870-6. PubMed ID: 21666485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
